Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma

Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma

Immune checkpoint inhibitors (ICIs) offer significant clinical benefits to a subset of cancer patients via the induction of a systemic T cell-mediated anti-cancer immune response. Thus, the dynamic characterization of T cell repertoires in the peripheral blood has the potential to demonstrate noninv...

Full description

Bibliographic Details
Main Authors:	Taigo Kato, Kazuma Kiyotani, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Yujiro Hayashi, Kosuke Nakano, Yu Ishizuya, Cong Wang, Koji Hatano, Atsunari Kawashima, Takeshi Ujike, Kazutoshi Fujita, Norio Nonomura, Motohide Uemura
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	OncoImmunology
Subjects:	immune checkpoint inhibitors predictive marker t cell receptor renal cell carcinoma next-generation sequencing
Online Access:	http://dx.doi.org/10.1080/2162402X.2020.1862948

Similar Items

Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer
by: Yujiro Hayashi, et al.
Published: (2020-05-01)

Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report
by: Tetsuya Yamamoto, et al.
Published: (2021-05-01)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
by: Yujiro Hayashi, et al.
Published: (2020-10-01)

Seronegative rheumatoid arthritis after combination therapy with ipilimumab and nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma
by: Yuki Nishimura, et al.
Published: (2023-03-01)

Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study
by: Akinaru Yamamoto, et al.
Published: (2022-04-01)

Prognostic significance of serum fucosylated pro-haptoglobin in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors
by: Taigo Kato, et al.
Published: (2023-10-01)

Trop-2 in Upper Tract Urothelial Carcinoma
by: Eisuke Tomiyama, et al.
Published: (2022-05-01)

Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma
by: Yoko Maegawa, et al.
Published: (2020-09-01)

Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
by: Yujiro Hayashi, et al.
Published: (2022-10-01)

Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
by: Eisuke Tomiyama, et al.
Published: (2020-07-01)

EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
by: Mototaka Sato, et al.
Published: (2013-01-01)

Characterization of the cryoablation-induced immune response in kidney cancer patients
by: Taigo Kato, et al.
Published: (2017-07-01)

Mucinous cystadenoma of the renal parenchyma presenting as a Bosniak IIF complex renal cyst
by: Takanori Nate, et al.
Published: (2023-03-01)

Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma
by: Toshihiro Uemura, et al.
Published: (2023-09-01)

STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma.
by: Kyosuke Matsuzaki, et al.
Published: (2018-01-01)

Erectile Dysfunction in Germ Cell Tumor Survivors
by: Koichi Okada, et al.
Published: (2021-07-01)

Selective arterial embolization for uncontrollable urethral hemorrhage in a patient with a left ventricular assist device
by: Yujiro Hayashi, et al.
Published: (2018-03-01)

Mutational Landscape and Environmental Effects in Bladder Cancer
by: Takuji Hayashi, et al.
Published: (2020-08-01)

Fucosylation in Urological Cancers
by: Kazutoshi Fujita, et al.
Published: (2021-12-01)

Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
by: Takuji Hayashi, et al.
Published: (2019-08-01)

Application of Anti-Inflammatory Agents in Prostate Cancer
by: Koji Hatano, et al.
Published: (2020-08-01)

A retroperitoneal primary undifferentiated pleomorphic sarcoma
by: Makishi Nakamura, et al.
Published: (2024-03-01)

A case of retroperitoneal liposarcoma extending through the inguinal canal to the thigh and lesser trochanter
by: Takahiro Maekawa, et al.
Published: (2023-07-01)

Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma
by: Fumie Yoshioka, et al.
Published: (2023-03-01)

Durable response of chemotherapy for cancer of unknown primary with unfavorable subset developed in retroperitoneal space
by: Atsuki Matsukawa, et al.
Published: (2021-07-01)

Secondary immune thrombocytopenic purpura with renal cell carcinoma
by: Shigeaki Nakazawa, et al.
Published: (2019-09-01)

Personalized immunotherapy in cancer precision medicine
by: Kazuma Kiyotani, et al.
Published: (2021-11-01)

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
by: Lili Ren, et al.
Published: (2019-04-01)

A case of mediastinal teratoma with malignant transformation into angiosarcoma and relapse with multiple bone metastases that was cured by a multidisciplinary treatment
by: Masaru Tani, et al.
Published: (2023-03-01)

The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer
by: Wei Zhang, et al.
Published: (2022-12-01)

Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
by: Soichi Matsumura, et al.
Published: (2023-06-01)

Monotherapy With Anti-CD70 Antibody Causes Long-Term Mouse Cardiac Allograft Acceptance With Induction of Tolerogenic Dendritic Cells
by: Jing Zhao, et al.
Published: (2021-02-01)

Deep immune B and plasma cell repertoire in non-small cell lung cancer
by: Akshay J. Patel, et al.
Published: (2023-06-01)

Architecture of the SARS-CoV-2-specific T cell repertoire
by: Ksenia V. Zornikova, et al.
Published: (2023-03-01)

The LCMV gp33-specific memory T cell repertoire narrows with age
by: Bunztman Adam, et al.
Published: (2012-08-01)

The T Cell Receptor Repertoire Diversity Following Hematopoietic Stem Cell Transplantation
by: Fahimeh Zamani, et al.
Published: (2022-10-01)

The positive and negative selection of B cells into the pre-immune repertoire
by: Cui, J
Published: (2024)

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
by: Kazutoshi Fujita, et al.
Published: (2023-02-01)

Emerging Relationship between the Gut Microbiome and Prostate Cancer
by: Makoto Matsushita, et al.
Published: (2023-10-01)

Characteristics of T-cell receptor repertoire of stem cell-like memory CD4+ T cells
by: Shiyu Wang, et al.
Published: (2021-08-01)